About this raise

Apotheka, with a valuation of $10 million, is raising funds on Wefunder. The company has built an electronic medical records platform integrated with blockchain for patient scheduling, registration, point of care, and revenue cycle. The blockchain technology works to make electronic medical records secure and scalable. Apotheka is working as a solution to integrate telemedicine onto the blockchain to facilitate self-assessments of COVID-19 patients. The solution is currently in use at Pacific Stemcells, Health Centurion, and Cedars Sinai TowerENT. Dennis Maliani founded Apotheka in September 2018. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $4,871,000. The campaign proceeds will be used for hiring, marketing, customer acquisition, infrastructure, R&D, and technology scaling.

Expand

Investment Overview

Not Funded: $78,450

Deal Terms

Total Commitments ($USD)

Platform
Wefunder
Start Date
01/10/2022
Close Date
08/31/2022
Min. Goal
$100,000
Max Goal
$4,871,000
Min. Investment

$100

Security Type

Convertible Note

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$10,000,000

Discount

10%

Company & Team

Company

Year Founded
2018
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
High
Capital Intensity
Low
Location
Beverly Hills, California
Business Type
Growth
Company Website
Visit Website

Team

Employees
12
Prior Founder Exits?
No
Founder Name
Dennis Maliani
Title
CEO

Financials

 Revenue
$11,970
 Monthly Burn
$961
 Runway
1.4 months

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$11,970

$7,494

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-11,533

$-11,908

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,364

$7,998

Accounts Receivable

$0

$0

Total Assets

$2,289

$9,493

Short-Term Debt

$0

$0

Long-Term Debt

$84,791

$80,462

Total Liabilities

$84,791

$80,462

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Offering Name Close Date Platform Valuation Total Raised Security Type Status Reg Type
Apotheka 08/31/2022 Wefunder $10,000,000 $78,450 Convertible Note Not Funded RegCF
Apotheka Systems 02/05/2021 Wefunder $6,000,000 $130,918 Equity - Common Funded RegCF
Apotheka Systems 03/17/2020 Fundopolis $10,000,000 $0 Equity - Common Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Apotheka on Wefunder 2022
Platform: Wefunder
Security Type: Convertible Note
Valuation: $10,000,000

Follow company

Follow Apotheka on Wefunder 2022

Buy Apotheka's Deal Report

Warning: according to the close date for this deal, Apotheka may no longer be accepting investments.

Apotheka Deal Report

Get Kingscrowd's comprehensive report on Apotheka including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Apotheka is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Apotheka deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge